Tianjin TEDA Biomedical Engineering Company Limited (SEHK:8189) entered into the Equity Transfer Agreement to acquire Shanghai Weidi Network Technology Company from three shareholders for CNY12.8 million on July 18, 2022. The net asset value of Shanghai Weidi as of 30 June 2022 was RMB13.1 million.
Tianjin TEDA Biomedical Engineering Company Limited
Equities
8189
CNE1000004H7
Agricultural Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 HKD | 0.00% | 0.00% | -15.73% |
1st Jan change | Capi. | |
---|---|---|
-15.73% | 18.19M | |
-16.79% | 14.6B | |
-5.91% | 13.54B | |
+4.01% | 12.31B | |
-18.61% | 9.22B | |
-11.66% | 7.42B | |
-.--% | 7.36B | |
-4.71% | 6.42B | |
-32.16% | 2.26B | |
+3.34% | 2.09B |
- Stock Market
- Equities
- 8189 Stock
- News Tianjin TEDA Biomedical Engineering Company Limited
- Tianjin TEDA Biomedical Engineering Company Limited entered into the Equity Transfer Agreement to acquire Shanghai Weidi Network Technology Company from three shareholders for CNY12.8 million.